Skip to main content
Clinical Trials/ACTRN12624000983505
ACTRN12624000983505Not yet recruitingUnknown

Evaluating the Impact of Two Whole-Food Diets on Obsessive-Compulsive Disorder in Adults: A Multiple Baseline Pilot Study

Sophia Dawson0 sites45 target enrollmentStarted: August 13, 2024Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
45

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Participants must be aged 18 years and over, and have a diagnosis of OCD from a medical doctor, psychologist or psychiatrist. Participants will also be required to score greater than or equal to 16 on the Yale Brown Obsessive Compulsive Scale (YBOCS), indicating moderate to severe symptoms of OCD. As the study is recruiting participants from all over New Zealand and will be run virtually, it is imperative that all participants have internet access.
  • Participants will be asked not to make any new treatment or any new lifestyle changes over the course of the study. This would include starting psychological treatment/ counselling, new exercise habits and/or other dietary changes aside from the ones recommended within this study.

Exclusion Criteria

  • Participants will be excluded from the study if they have a diagnosis of any of the following psychiatric conditions: personality disorders, eating disorders, schizophrenia spectrum and other psychotic disorders, bipolar disorder, or a substance abuse disorder. These conditions have been excluded due to their potential of disrupting participant compliance.
  • Participants will also be excluded from the study if they are unwilling to make dietary changes or unwilling to attend follow up appointments. If participants are currently receiving psychological therapy, they will be advised that they can take part in the trial once their therapy has concluded. Participants are able to take part in this study if they are currently taking psychiatric medications; however, it is important that they have been taking these for at least 6 months prior to commencing the trial.

Investigators

Sponsor
Sophia Dawson

Similar Trials